Lv1
20 积分 2024-01-17 加入
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1天前
待确认
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
2天前
已完结
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
2个月前
已完结
Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology
2个月前
已完结
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
2个月前
已完结
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
2个月前
已完结
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
3个月前
已完结
MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients
3个月前
已完结
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
5个月前
已完结
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
5个月前
已完结
皖公网安备34019202002308
